Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 2 | |
Outperform | 3 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in CHF
The 6 analysts offering 12 month price targets for Basilea Pharmaceutica AG Allschwil have a median target of 76.85, with a high estimate of 120.00 and a low estimate of 52.00. The median estimate represents a 86.08% increase from the last price of 41.30.
High | 190.6% | 120.00 |
Med | 86.1% | 76.85 |
Low | 25.9% | 52.00 |
Earnings history & estimates in CHF
Average growth rate | +25.00% |
More ▼
Revenue history & estimates in CHF
Average growth rate | +4.37% |
More ▼